NasdaqGS:MRNABiotechs
Is Moderna (MRNA) Now Fairly Priced After Its Recent Share Price Rebound?
If you are wondering whether Moderna's current share price still reflects its long term potential or if the market has moved on, you are not alone.
The stock closed at US$40.11 recently, with a 1.9% decline over the last 7 days, a 1.3% gain over 30 days, a 30.0% return year to date, a 25.7% return over 1 year, and declines of 76.7% and 76.3% over 3 and 5 years respectively.
That mix of shorter term strength and longer term weakness has come alongside ongoing attention on Moderna's mRNA...